Secobarbital Conjugate (BSA)

Our Secobarbital - BSA product is an Antigen Conjugate based on a BSA (Bovine Serum Albumin) carrier, attached to proprietary Secobarbital derivatives.

• Western blotting.
• Enzyme-linked immunosorbent assay (ELISA).
• Dot blotting.

Secobarbital Sodium (marketed by Eli Lilly and Company, and subsequently by other companies as described below, under the brand name Seconal) is a barbiturate derivative drug that was first synthesized in 1928. It possesses anaesthetic, anticonvulsant, sedative and hypnotic properties. In the United Kingdom, it was known as Quinalbarbitone.